Iperion introduces the IDMP Readiness Questionnaire

In June, EMA released the draft of the 2nd version of the ‘IDMP/SPOR PMS Implementation Guide’ which is now in the consultation phase. This new release contains an updated chapter 2 (Medicinal Product Information) and a first version of chapter 3 for the process on how product data should be submitted as part of the […]

The IDMP data standards provide structured medicinal, pharmaceutical product and substance data models, as well as mechanisms to uniquely identify products and their components. As well as facilitating a wide range of exciting regulatory and healthcare use cases, the standards can help organizations overcome traditional information silos and inconsistent data quality across different functional areas, […]

The suite of ISO IDMP data standards has the potential to support a broad spectrum of transformational new healthcare and regulatory applications. Yet articulating the benefits of IDMP adoption to a CEO or CIO remains a challenge for project proposers, who must confront the common perception that this is merely another compliance cost. Iperion Life […]

IDMP supports the core missions of industry and regulators, which is grounded upon the premise that each plays a vital role in promoting and protecting public health.  The external relationships and information obtained from healthcare providers and patients help complete the co-dependent ecosystem of life science, which is used to inform and impact clinical research […]